News Focus
News Focus
Replies to #94621 on Biotech Values
icon url

Do DD

04/22/10 4:14 PM

#94623 RE: genisi #94621

ACUR panel voted 19-1 against approval. This does not bode well for their total pipeline since Niacin, which was the no way José component afas the panel was concerned, is rather prevalent as a productcomponent in their pipeline...